Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2008/060690external-prioritypatent/WO2009021992A2/en
Application filed by Bayer Ip GmbhfiledCriticalBayer Ip Gmbh
Publication of CU20100028A7publicationCriticalpatent/CU20100028A7/en
Publication of CU23955B1publicationCriticalpatent/CU23955B1/en
Compuestos de fórmula (I) los tautómeros o los estereoisómeros de estos, o las sales de estos, donde el anillo B y la pirimidina a la que está fusionado, R4, R5, R6 y R7 tienen los valores indicados en la descripción y las reivindicaciones, y son inhibidores eficaces de la vía Pi3K/Akt.Compounds of formula (I) the tautomers or stereoisomers thereof, or the salts thereof, wherein the ring B and the pyrimidine to which it is fused, R4, R5, R6 and R7 have the values indicated in the description and claims , and are effective inhibitors of the Pi3K / Akt pathway.
CU2010000028A2007-08-142010-02-12
BICYCLIC PYRIMIDINS FUSED AS EFFECTIVE INHIBITORS OF THE VIA Pi3K / Akt
CU23955B1
(en)
DERIVATIVES OF N- (HETERO) ARIL-PIRROLIDINA DE PIRAZO-4-IL-PIRROLO [2,3-D] PIRIMIDINES AND PIRROL-3-IL-PIRROLO [2,3-D] PYRIMIDINES AS IHNIBITORS OF THE JANUS KINASE
NEW DERIVATIVES (HETEROCICLO - TETRAHIDRO - PIRIDIN) - (PIPERAZINIL) - 1 - ALCANONE AND (HETEROCICLO - DIHIDRO - PIRROLIDIN) - (PIPERAZINIL) - 1 - ALCANONA AND ITS USE AS INHIBITORS OF p75